Motilin receptor

Target ID: CHEMBL2203

Organism: Homo sapiens

Type: SINGLE PROTEIN

View on ChEMBL

Molecules

Name SMILES Bioactivity Structure
METHOTREXATE CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1 ID50: 6.2 nM
FUROSEMIDE NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl Ki: 100000.0 nM
FLUVASTATIN CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 IC50: 28.0 nM
ETHACRYNIC ACID C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl mequiv of Na+/kg: 4.14 0-5h
BOSUTINIB COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl IC50: 1.3 nM
ERLOTINIB C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 IC50: 1450.0 nM
AMITRIPTYLINE CN(C)CCC=C1c2ccccc2CCc2ccccc21 IC50: 61.0 nM
AMPHOTERICIN B C[C@@H]1[C@H](O)[C@@H](C)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@H]1C)C[C@H](O)[C@H]2C(=O)O MIC: 4000.0 ug.mL-1
ATENOLOL CC(C)NCC(O)COc1ccc(CC(N)=O)cc1 Pc: 1000000.0 cm s-1
EMETINE CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 IC50: 40.0 nM
ESMOLOL COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1 Kd: 100.0 nM
FLUCONAZOLE OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F IC80: 2.8 ug ml-1
CANDESARTAN CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 T1/2: 9.0 hr
TADALAFIL CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O IC50: 6.7 nM
DICHLORPHENAMIDE NS(=O)(=O)c1cc(Cl)c(Cl)c(S(N)(=O)=O)c1 Ki: 1200.0 nM
ACEBUTOLOL CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1 LD50: 76.0 mg.kg-1
ASTEMIZOLE COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1 Binding energy: 11.3 kCal mol-1
NAFAMOSTAT N=C(N)Nc1ccc(C(=O)Oc2ccc3cc(C(=N)N)ccc3c2)cc1 IC50: 12000.0 nM
QUERCETIN O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 IC50: 32870.0 nM
AMILORIDE N=C(N)NC(=O)c1nc(Cl)c(N)nc1N Pc: 780000.0 cm s-1
SILDENAFIL CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 Pc: 87000000.0 cm s-1
VOGLIBOSE OCC(CO)N[C@H]1C[C@](O)(CO)[C@@H](O)[C@H](O)[C@H]1O IC50: 110.0 nM
FULVESTRANT C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O IC50: 0.49 nM
TOFACITINIB C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12 IC50: 13.0 nM
ESTRADIOL C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O IC50: 1.5 nM
OXATOMIDE O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1 A10: 0.014 mg l-1
BAZEDOXIFENE Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 IC50: 23.0 nM
PENTOSTATIN OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O Ki: 0.0025 nM

Top Fragments

SMILES Avg pKi Count Structure
[3*]O[3*] 6.79 272
[5*]N[5*] 7.01 225
[16*]c1ccc([16*])cc1 6.88 152
[1*]C([6*])=O 6.59 115
[3*]OC 7.32 113